Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Full analysis of Phase 2 results, including data from the 52-week treat-through LTE phase, is expected to inform development strategy and partnership opportunities for VTX958 SAN DIEGO, Feb. 18, 2025 ...

City councillors received a comprehensive presentation on the final Growth Management Strategy (GMS) at its committee meeting on Tuesday, February 4, marking a major step in the municipality’s long-te ...

A consultant argues these homes, most of which have one bathroom, are in a "motivational dead zone," and aren't going to get ...

Novant Health Inc. pitch to investors features two ambitious initiatives: the first: tripling annual revenue from $10 billion ...

In no particular order, here are the top 10 AI companies to watch that are each making significant strides in their ...

MUSC Health-Orangeburg CEO Walter Bennett III presented expansions in specialist care and research opportunities at a recent Bamberg County Council meeting.

The report was unveiled as part of Dubai Chambers’ participation as a Featured Partner in the World Governments Summit 2025 ...

The Deputy Speaker of Nigeria’s House of Representatives, Hon. Benjamin Kalu, has announced a significant reduction in Nigeria’s debt servicing burden under President Bola Tinubu’s administration, ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Applied DNA Sciences, Inc. (NASDAQ: APDN) Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $ ...

The Real Estate Regulatory Authority (Aqarat) hosted the second forum for real estate developers on Monday which aimed to ...